Literature DB >> 3986769

Varying degrees of amplification of the N-ras oncogene in the human breast cancer cell line MCF-7.

K A Graham, C L Richardson, M D Minden, J M Trent, R N Buick.   

Abstract

The oncogene N-ras has been found to be amplified (congruent to 20 copies) in the human breast carcinoma cell line MCF-7. The amplified sequences have been localized to a marker chromosome by in situ hybridization. Sublines of MCF-7, serially passaged in different laboratories, have marked variation in the degree of N-ras amplification. The differing degrees of amplification of N-ras are further evidence of heterogeneity within MCF-7 subclones. The phenomenon may not have general relevance for breast cancer, since other breast cancer cell lines and DNA from patient biopsies failed to show evidence of N-ras amplification.

Entities:  

Mesh:

Year:  1985        PMID: 3986769

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells.

Authors:  Dominic Leiser; Michaela Medová; Kei Mikami; Lluís Nisa; Deborah Stroka; Andree Blaukat; Friedhelm Bladt; Daniel M Aebersold; Yitzhak Zimmer
Journal:  Mol Oncol       Date:  2015-04-14       Impact factor: 6.603

2.  Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer.

Authors:  M Resnicoff; E E Medrano; O L Podhajcer; A I Bravo; L Bover; J Mordoh
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  The use of restriction fragment polymorphisms to identify the cell line MCF-7.

Authors:  K A Graham; J M Trent; C K Osborne; C M McGrath; M D Minden; R N Buick
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 4.  Cytogenetic and molecular biologic alterations in human breast cancer: a review.

Authors:  J M Trent
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Induction of the apoptosis inhibitor ARC by Ras in human cancers.

Authors:  Lily Wu; Young-Jae Nam; Gloria Kung; Michael T Crow; Richard N Kitsis
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

6.  Ras in cancer and developmental diseases.

Authors:  Alberto Fernández-Medarde; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

7.  Biological differences among MCF-7 human breast cancer cell lines from different laboratories.

Authors:  C K Osborne; K Hobbs; J M Trent
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

8.  Cytogenetic studies on human breast carcinomas.

Authors:  E Gebhart; S Brüderlein; M Augustus; E Siebert; J Feldner; W Schmidt
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

9.  The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis.

Authors:  Jingyung Hur; Jessica Chesnes; Kathryn R Coser; Roseanna S Lee; Peter Geck; Kurt J Isselbacher; Toshi Shioda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.

Authors:  C W Taylor; W S Dalton; P R Parrish; M C Gleason; W T Bellamy; F H Thompson; D J Roe; J M Trent
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.